Effect of monosodium glutamate on testicular tissue of paclitaxel-treated mice: An experimental study

BACKGROUND: Paclitaxel (PTX), a chemotherapeutic agent, and monosodium glutamate (MSG) have oxidative effects on testicular tissue. OBJECTIVE: In this study, the effects of MSG administration on the exacerbation of testicular tissue alterations related to PTX treatment were evaluated. MATERIALS AND METHODS: MSG (30 & 60 mg/kg i.p.) was administrated to six groups (n = 8/each) of adult mice before or after PTX treatment: control, PTX-treated, MSG30 + PTX, MSG60 + PTX, PTX + MSG30, and PTX + MSG60. Following the euthanizing, the body weight measurement, pituitary–testicular axis hormonal analysis and serum lipid peroxidation index assessment was prepared, testicular histomorphometry (tubular diameter and germinal epithelium height), immunohistochemistry of p53 was completed. Microscopic indices of spermatogenesis (tubular differentiation, spermiogenesis and repopulation indices) were studied. RESULTS: Body weight was not changed significantly. The levels of testosterone (p = 0.0001), follicle stimulating hormone (p = 0.019), and luteinizing hormone (p = 0.08) were decreased while the level of lipid peroxidation index was increased (p = 0.208) in the treated groups. The histomorphometry indices (p [Formula: see text] 0.0001 and p = 0.001, respectively), germ cells population (p [Formula: see text] 0.05) and microscopic indices of spermatogenesis (p = 0.001, p = 0.005, p [Formula: see text] 0.0001, respectively) were significantly reduced in all treated groups. The administration of MSG before PTX treatment induces more changes. The most positive reaction to p53 was observed in MSG30 or 60 + PTX groups compared to other groups. CONCLUSION: The administration of MSG could intensify testicular tissue alterations related to PTX chemotherapy.